Patient-specific Induced Pluripotent Stem Cells as a Platform for Disease Modeling, Drug Discovery and Precision Personalized Medicine

Review Article - (2012) Volume 0, Issue 0

Wilson Young¹, Sunita L. D’Souza^2,⁴, Ihor R. Lemischka^2,^3,⁴ and Christoph Schaniel^2,⁴^*: ¹Department of Medicine, Division of Cardiology, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com; ²Department of Developmental and Regenerative Biology, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com; ³Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com; ⁴Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, NY, USA, E-mail: WilsonYoung@gmail.com

^*Corresponding Author: